A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma
Status:
Terminated
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Study Hypothesis: Patients with local renal cell carcinoma who are treated neoadjuvantly with
Sutent may show a radiologic response to the study drug (Sutent).
The study is looking at the neoadjuvant (pre-surgery) administration of Sutent in patients
with localized kidney cancer. The purpose of this research is also to evaluate both the
safety and effectiveness of Sutent in this patient population.